Search Tag: Angiotensin Receptor-Neprilysin Inhibitors

Cardiology Management

2019 15 Mar

Heart failure (HF) is a major health problem and results in significant morbidity and mortality. The use of Angiotensin Receptor-Neprilysin Inhibitor (ARNI) in patients hospitalised for HF may be a good strategy to improve morbidity and mortality in patients with heart failure with reduced ejection fraction (HFrEF). Different studies have...Read more